ATE537817T1 - Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung - Google Patents

Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung

Info

Publication number
ATE537817T1
ATE537817T1 AT08733215T AT08733215T ATE537817T1 AT E537817 T1 ATE537817 T1 AT E537817T1 AT 08733215 T AT08733215 T AT 08733215T AT 08733215 T AT08733215 T AT 08733215T AT E537817 T1 ATE537817 T1 AT E537817T1
Authority
AT
Austria
Prior art keywords
delivery
production
medicinal products
nanoparticle carrier
nanoparticle
Prior art date
Application number
AT08733215T
Other languages
English (en)
Inventor
Lonji Kalombo
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Application granted granted Critical
Publication of ATE537817T1 publication Critical patent/ATE537817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08733215T 2008-02-18 2008-02-18 Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung ATE537817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ZA2008/000012 WO2009105792A1 (en) 2008-02-18 2008-02-18 Nanoparticle carriers for drug administration and process for producing same

Publications (1)

Publication Number Publication Date
ATE537817T1 true ATE537817T1 (de) 2012-01-15

Family

ID=39790304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08733215T ATE537817T1 (de) 2008-02-18 2008-02-18 Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung

Country Status (14)

Country Link
US (1) US8518450B2 (de)
EP (1) EP2249817B8 (de)
JP (1) JP5575667B2 (de)
CN (1) CN101951895B (de)
AP (1) AP2966A (de)
AT (1) ATE537817T1 (de)
AU (1) AU2008351331B2 (de)
CA (1) CA2714429C (de)
DE (1) DE112008003727T5 (de)
ES (1) ES2397016B1 (de)
GB (1) GB2469965B (de)
MX (1) MX2010008902A (de)
WO (1) WO2009105792A1 (de)
ZA (1) ZA201006639B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815294B2 (en) * 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
TWI462753B (zh) * 2011-11-29 2014-12-01 Univ Nat Chiao Tung 雙乳化核殼奈米結構及其製備方法
WO2013117671A1 (fr) * 2012-02-07 2013-08-15 Centre National De La Recherche Scientifique (C.N.R.S) Préparation de nanoparticules par évaporation flash
US9283298B2 (en) 2013-09-25 2016-03-15 Clemson University Compliant surgical adhesive
US9850521B2 (en) * 2014-08-01 2017-12-26 Agilent Technologies, Inc. In vitro assay buffer for Cas9
MA44833A (fr) * 2015-08-17 2018-06-27 Phosphorex Inc Nanoparticules extrêmement petites de polymères dégradables
TWI663991B (zh) * 2016-03-23 2019-07-01 中央研究院 薄殼聚合物奈米粒子及其用途
JP7465876B2 (ja) * 2018-08-17 2024-04-11 スメラ クシシュトフ 親油性化合物及び親水性化合物のカプセル化のためのナノカプセル・イン・ナノカプセルタイプのマルチコンパートメントシステム並びに関連する製造方法
CN109628547B (zh) * 2018-12-14 2022-02-25 陕西师范大学 一种改性磁珠、制备方法及其应用
CN113924121B (zh) * 2019-05-14 2025-12-09 科学和工业研究委员会 用于增强疏水活性化合物的水溶解和吸收的聚合物-脂质纳米复合物
CN116256455B (zh) * 2023-03-20 2025-05-30 东营天东制药有限公司 鉴别猪肠黏膜来源肝素中牛肺来源肝素掺杂含量的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US20040018236A1 (en) * 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7354886B2 (en) * 1999-07-29 2008-04-08 Baker Hughes Incorporated Pumpable multiple phase compositions for controlled release applications downhole
CN1406140A (zh) * 2000-02-28 2003-03-26 吉倪塞思公司 纳米胶囊包封系统与方法
DK1328612T3 (da) * 2000-10-27 2007-09-17 Genencor Int Partikel med substitueret polyvinylalkohol-coating
EP1275378B1 (de) * 2001-07-10 2009-04-15 Canon Kabushiki Kaisha Partikel auf Basis von Polyhydroxyalkanoat und Verfahren zu deren Herstellung
JP2003175092A (ja) * 2001-07-10 2003-06-24 Canon Inc ポリヒドロキシアルカノエートを含有する粒状体及びその製造方法ならびにその用途
SI21222A (sl) * 2002-05-28 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo nanodelcev
ITTO20020452A1 (it) * 2002-05-29 2003-12-01 Vhit Spa Valvola pneumatica di limitazione del livello di depressione e sistema di frenatura comportante tale valvola.
EP1595549A4 (de) * 2003-02-19 2010-09-22 Takeda Pharmaceutical Dispergens für zubereitungen mit verzögerter freisetzung
ES2420479T3 (es) * 2006-08-31 2013-08-23 Sk Chemicals, Co., Ltd. Procedimiento para la producción de microesferas cargadas con fármacos y microesferas cargadas con fármacos producidas mediante el mismo
DE602007012559D1 (de) * 2006-09-08 2011-03-31 Univ Johns Hopkins H die schleimhaut

Also Published As

Publication number Publication date
GB201013546D0 (en) 2010-09-29
DE112008003727T5 (de) 2011-04-21
CA2714429A1 (en) 2009-08-27
GB2469965A (en) 2010-11-03
MX2010008902A (es) 2011-03-02
EP2249817B1 (de) 2011-12-21
HK1145973A1 (en) 2011-05-13
JP5575667B2 (ja) 2014-08-20
GB2469965B (en) 2012-06-20
AP2010005389A0 (en) 2010-10-31
AU2008351331A1 (en) 2009-08-27
GB2469965A8 (en) 2010-11-24
EP2249817A1 (de) 2010-11-17
US8518450B2 (en) 2013-08-27
ES2397016B1 (es) 2014-01-17
JP2011512418A (ja) 2011-04-21
CA2714429C (en) 2015-04-28
AU2008351331B2 (en) 2014-07-17
AP2966A (en) 2014-09-30
CN101951895B (zh) 2013-11-06
ES2397016A1 (es) 2013-03-04
CN101951895A (zh) 2011-01-19
ZA201006639B (en) 2012-03-28
EP2249817B8 (de) 2012-03-21
WO2009105792A1 (en) 2009-08-27
US20110033550A1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
ATE537817T1 (de) Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung
DE602008005919D1 (de) Verfahren zur herstellung von teeprodukten und hierdurch erhältliche produkte
EP2536675A4 (de) Integrierter prozess und verfahren zur herstellung von (e)-1-chlor-3,3,3-trifluorpropen
EP2348834A4 (de) Verfahren zur herstellung von polymer-nanopartikeln und formulierungen von wirkstoffen
EP2049291A4 (de) Nanopartikel-beschichtungen und verfahren zu ihrer herstellung
EP2366794A4 (de) Verfahren zur herstellung von poly-3-hydroxyalkanoat und poly-3-hydroxyalkanoatagglomerat
EP2407539A4 (de) Multimere sirna und verfahren zu ihrer herstellung
EP2425843A4 (de) Dentinverkalkungsmittel und verfahren zu seiner herstellung
DE112009000918A5 (de) Magnetisches Verbundmaterial und Verfahren zu seiner Herstellung
EP2424847A4 (de) Verfahren zur herstellung von rivaroxaban und zwischenprodukten davon
EP2433974A4 (de) Wässrige polyurethanharzdispersion und verfahren zu ihrer herstellung
EP2812040A4 (de) Erzeugnisse mit tantalbeschichteten nanostrukturen sowie verfahren zu ihrer herstellung und verwendung
EP2282705C0 (de) Gesteuerte einsetzbare medizinische vorrichtung und verfahren zu ihrer herstellung
EP2247196A4 (de) Süssmittelzusammensetzungen und verfahren zu ihrer herstellung
EP3620465C0 (de) Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
EP2573257A4 (de) Hybridseil und verfahren zu seiner herstellung
EP2673405C0 (de) Verfahren zur herstellung von faser-, band- und folienprodukten und verbundstoffen
DE102011050837A8 (de) Sensor und Verfahren zur Herstellung desselben
EP2412298A4 (de) Seitenemissionsvorrichtung und verfahren zu ihrer herstellung
EP2626058A4 (de) Mittel zur versiegelung der zahn-canaliculi und verfahren zu seiner herstellung
EP2804244A4 (de) Sauerstoffreduktionskatalysator und verfahren zu seiner herstellung
EP2410855A4 (de) Verfahren zur herstellung von alogliptin
EP3821910C0 (de) Oligosaccharid und verfahren zur herstellung davon
EP2297079A4 (de) Verfahren zur herstellung von glycolsäure
DE102011050839A8 (de) Sensor und Verfahren zur Herstellung desselben